Your only malignant pleural mesothelioma news source! Click on each item to read full story.   Aduro Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at ASCO read story Aduro BioTech, Inc. announces two poster presentations at the upcoming American Society of Clinical Oncology annual meeting in Chicago. Dr. Raffit Hassan, Head of the Solid Tumor Immunotherapy Section at the Laboratory of Molecular Biology at the National Cancer Institute, will present data from Aduro’s Phase 1B clinical trial in patients with malignant pleural mesothelioma .   New Mesothelioma Test May Revolutionize Diagnosis and Treatment According to Surviving Mesothelioma read story Surviving Mesothelioma reports that researchers from among the world’s top cancer centers say they have developed a test capable of recognizing the molecular “fingerprint” of malignant pleural mesothelioma. (PRWeb May 03, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10697838.htm   $150,000 Donation from Long-Time Supporter of Mesothelioma Research Helps Support The Pacific Meso Center's 2013 Agenda read story LOS ANGELES, May 2, 2013 /PRNewswire/ -- The Pacific Meso Center (PMC) is pleased to announce receipt of a generous donation from Roger G. Worthington of the Law Office of Worthington & Caron, P.C., a ...   Aduro Scientific Advisory Board Member Daniel A. Portnoy Elected to the National Academy of Sciences read story Aduro BioTech, Inc. announces that UC Berkeley Professor Daniel A. Portnoy has been elected to the National Academy of Sciences , one of the highest honors given to a scientist in the United States.   Bridge farewelled at State funeral read story His casket was carried in to the tune of Bridge Over Troubled Water, reflecting the role Ernie Bridge played in reconciliation and how he lived his life.   CORRECTING and REPLACING Aduro Announces Collaboration with Johns Hopkins University to Evaluate Aduro Therapeutic ... read story In first graph, last sentence of release dated April 22, 2013, organization name should read: Melanoma Research Alliance .   Press Release read story Aduro BioTech Inc. Posted on:25 Apr 13 In first graph last sentence of release dated April 22 2013 organization name should read:Â Melanoma Research Alliance (sted Melanoma Research Foundation).